Meningococcal Group C Vaccine (Royal Bio-Pharmaceutical)

C群脑膜炎球菌结合疫苗（罗益生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal Group C Vaccine (Royal Bio-Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusDiscontinued (IND)

Highest Status in ChinaDiscontinued

Originator CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRoyal (Wuxi) Bio-Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsMeningitis

Other Information

ATC CodeN/A